Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-15 4:37 pm Purchase | 2025-03-31 | 13G | SEPTERNA INC SEPN | BIOTECHNOLOGY VALUE FUND L P | 4,396,124 9.900% | 1,944,100 (+79.29%) | Filing History |
| 2025-05-15 4:35 pm Purchase | 2025-03-31 | 13G | ITEOS THERAPEUTICS INC. ITOS | BIOTECHNOLOGY VALUE FUND L P | 3,075,000 8.100% | 750,000 (+32.26%) | Filing History |
| 2025-05-15 4:33 pm Purchase | 2025-03-31 | 13G | MONTE ROSA THERAPEUTICS INC CO GLUE | BIOTECHNOLOGY VALUE FUND L P | 5,660,132 9.200% | 1,266,922 (+28.84%) | Filing History |
| 2025-05-15 4:31 pm Sale | 2025-03-31 | 13G | GH RESH PLC SHS GHRS | BIOTECHNOLOGY VALUE FUND L P | 8,827,712 14.200% | -1,572,446 (-15.12%) | Filing History |
| 2025-05-15 4:29 pm Sale | 2025-03-31 | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | BIOTECHNOLOGY VALUE FUND L P | 4,632,749 9.990% | -201,548 (-4.17%) | Filing History |
| 2025-05-15 4:27 pm Sale | 2025-03-31 | 13G | ELEVATION ONCOLOGY INC ELEV | BIOTECHNOLOGY VALUE FUND L P | 4,440,000 7.000% | -1,790,845 (-28.74%) | Filing History |
| 2025-05-15 4:25 pm Purchase | 2025-03-31 | 13G | CIDARA THERAPEUTICS INC NE CDTX | BIOTECHNOLOGY VALUE FUND L P | 1,252,441 9.990% | 158,942 (+14.54%) | Filing History |
| 2025-05-09 5:50 pm Unchanged | 2025-05-07 | 13D | INVENTIVA SA ADR IVA | BIOTECHNOLOGY VALUE FUND L P | 8,545,499 6.100% | 0 (Unchanged) | Filing History |
| 2025-04-16 6:49 pm Sale | 2025-04-14 | 13G | THIRD HARMONIC BIO INC THRD | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -2,372,933 (Position Closed) | Filing History |
| 2025-04-09 09:00 am Unchanged | 2025-04-09 | 13D | ESSA PHARMA INC EPIX | BIOTECHNOLOGY VALUE FUND L P | 8,748,629 19.700% | 0 (Unchanged) | Filing History |
| 2025-02-14 4:28 pm Purchase | 2024-12-31 | 13G | VISTAGEN THERAPEUTICS INC VTGN | BIOTECHNOLOGY VALUE FUND L P | 3,084,324 9.970% | 307,079 (+11.06%) | Filing History |
| 2025-02-14 4:26 pm Purchase | 2024-12-31 | 13G | VERASTEM INC VSTM | BIOTECHNOLOGY VALUE FUND L P | 4,706,551 9.990% | 427,030 (+9.98%) | Filing History |
| 2025-02-14 4:24 pm Sale | 2024-12-31 | 13G | TYRA BIOSCIENCES INC TYRA | BIOTECHNOLOGY VALUE FUND L P | 3,944,194 7.800% | -717,000 (-15.38%) | Filing History |
| 2025-02-14 4:22 pm Sale | 2024-12-31 | 13G | IKENA ONCOLOGY INC IKNA | BIOTECHNOLOGY VALUE FUND L P | 333,880 8.300% | -63,550 (-15.99%) | Filing History |
| 2025-02-14 4:20 pm Sale | 2024-12-31 | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | BIOTECHNOLOGY VALUE FUND L P | 4,834,297 9.990% | -2,548,345 (-34.52%) | Filing History |
| 2025-02-14 4:11 pm Purchase | 2024-12-31 | 13G | FORTE BIOSCIENCES INC FBRX | BIOTECHNOLOGY VALUE FUND L P | 643,622 9.990% | 524,338 (+439.57%) | Filing History |
| 2025-02-14 4:07 pm Sale | 2024-12-31 | 13G | 89BIO INC ETNB | BIOTECHNOLOGY VALUE FUND L P | 4,333,885 3.600% | -2,477,746 (-36.38%) | Filing History |
| 2025-02-14 4:05 pm Purchase | 2024-12-31 | 13G | CIDARA THERAPEUTICS INC NE CDTX | BIOTECHNOLOGY VALUE FUND L P | 1,093,499 9.990% | 390,373 (+55.52%) | Filing History |
| 2025-02-14 4:02 pm Purchase | 2024-12-31 | 13G | AVALO THERAPEUTICS INC PAR AVTX | BIOTECHNOLOGY VALUE FUND L P | 1,038,542 9.990% | 71,243 (+7.37%) | Filing History |
| 2025-02-04 8:09 pm Purchase | 2025-01-27 | 13G | KURA ONCOLOGY INC KURA | BIOTECHNOLOGY VALUE FUND L P | 5,912,554 7.500% | 2,504,500 (+73.49%) | Filing History |